Get the Stockscreener App
5.75
8.73%
-0.55
After Hours:
6.32
0.57
+9.91%
BiomX Inc stock is traded at $5.75, with a volume of 107.69K.
It is down -8.73% in the last 24 hours and up +26.10% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$6.30
Open:
$5.4
24h Volume:
107.69K
Relative Volume:
0.13
Market Cap:
$9.16M
Revenue:
-
Net Income/Loss:
$-23.14M
P/E Ratio:
-5.6756
EPS:
-1.0131
Net Cash Flow:
$-29.23M
1W Performance:
+25.82%
1M Performance:
+26.10%
6M Performance:
-41.46%
1Y Performance:
-53.29%
1-Day Range:
$5.30
$6.9399
1-Week Range:
$4.06
$6.9399
52-Week Range:
$1.5004
$14.71
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
5.75 | 10.04M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
PHGE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
[Form 3] BiomX Inc. Initial Statement of Beneficial Ownership - Stock Titan
Leadership shake-up at BiomX (PHGE) as executives quit and new CFO named - Stock Titan
Aug Wrap: Does BiomX Inc have a sustainable dividendJuly 2025 Volume & AI Driven Price Predictions - baoquankhu1.vn
Earnings Miss: Can BiomX Inc maintain sales growthPortfolio Value Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
PHGE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BiomX (PHGE) adds two independent board members after Alan Moses resigns - Stock Titan
PHGE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BiomX: Meeting adjourned and rescheduled due to lack of quorum; voting instructions remain valid - TradingView
BiomX: Meeting adjourned for lack of quorum; rescheduled for March 11, 2026 - TradingView
Bull Bear: Does BiomX Inc outperform in volatile marketsJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
BiomX Inc. SEC 10-K Report - TradingView
BiomX Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
MSN Money - MSN
Alyeska details 2.5% BiomX (PHGE) stake in amended 13G filing - Stock Titan
Does BiomX Inc. stock have upside surprise potentialJuly 2025 Drop Watch & Risk Managed Investment Signals - mfd.ru
BiomX Inc. Announces Board Changes - marketscreener.com
Is BiomX Inc. trading at a discountJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - mfd.ru
PHGE Should I Buy - Intellectia AI
Deerfield’s 9.99% BiomX (PHGE) stake and board resignation detail - Stock Titan
BiomX Inc. deconsolidates Israeli subsidiary after insolvency proceedings By Investing.com - Investing.com India
BiomX Inc. deconsolidates Israeli subsidiary after insolvency proceedings - Investing.com
BiomX Restructures After Insolvency and Executive Terminations - TipRanks
Growth Value: Why is BiomX Inc stock going upQuarterly Portfolio Report & High Return Stock Watch Alerts - baoquankhu1.vn
Market Outlook: Is BiomX Inc trading at a discount2025 Market WrapUp & Safe Entry Trade Reports - baoquankhu1.vn
BiomX Inc. Announces Termination of Officer Roles at BiomX Ltd. - TradingView
BiomX (PHGE) Announces Plan to Offer 5.31 Million Shares of Comm - GuruFocus
Buyout Rumor: Can BiomX Inc grow without dilution2025 Bull vs Bear & High Accuracy Investment Signals - baoquankhu1.vn
Aug Opening: Can PENG expand its profit margins2025 Volume Leaders & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
BiomX Inc. Reports Q3 2025 Financial Results and Program Updates - MSN
Aug Macro: How does SNSE correlate with NasdaqWeekly Investment Recap & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Growth Recap: Can BiomX Inc. grow without dilutionWeekly Trade Review & Risk Controlled Swing Alerts - mfd.ru
What's Driving the Market Sentiment Around BiomX Inc? - Benzinga
Growth Recap: Does BiomX Inc outperform in volatile marketsTake Profit & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Three Stocks Jumped On Big News And Bigger Questions - Finimize
BiomX Issues Statement Regarding Recent Common Stock Trading Activity - The Manila Times
BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading - TradingView
BiomX Secures $3M Via Private Placement to Boost Financial Fortunes - StocksToTrade
BiomX’s $3M Private Placement Signals Strategic Shift - timothysykes.com
BiomX stock jumps in premarket after SEC filing flags new 19.99% holder - TechStock²
Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga
BiomX Surges In Pre-Market After Pyu Pyu Capital Discloses 19.99% Stake - Nasdaq
Biomx Inc Shares Surge After 13D Filing Reveals Major Stake - Intellectia AI
Setup Watch: Whats next for BiomX Inc stockWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Short Squeeze: Is BiomX Inc a cyclical or defensive stockPortfolio Value Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Aug Chart Watch: Does BiomX Inc have strong fundamentalsJuly 2025 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Patterns Watch: Does BiomX Inc stock have upside surprise potentialGap Up & Weekly Sector Rotation Insights - baoquankhu1.vn
Will BiomX Inc. outperform its industry peers2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - bollywoodhelpline.com
Aug Retail: Will BiomX Inc outperform its industry peersWeekly Investment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Insider at BiomX (PHGE) files Form 3 on preferred stock, warrants - Stock Titan
BiomX Completes Private Placement and Board Expansion - The Globe and Mail
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):